SCHEMBL7044404

SCHEMBL7044404

O=C(Nc1ccc(Cl)cc1)Nc1nc2cc(OS(=O)(=O)c3ccc(-n4ccnc4)cc3)ccc2[nH]1.O=C(Nc1ccc(Cl)cc1)Nc1nc2cc(OS(=O)(=O)c3ccc(NC4CCCC4)cc3)ccc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
CNR1 P21554 1/20 0.37
MMP1 P03956 2/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
F10 P00742 1/20 0.35
IDH1 O75874 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
FAAH O00519 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7044049 0.93 KDR (0.41) ROCK2MAPTHTTCNR1MMP1
SCHEMBL7176912 0.93 MAPT (0.39) ROCK2MAPTHTTMMP1MEN1
SCHEMBL5033479 0.92 MEN1 (0.42) MAPTMEN1KMT2AF10IDH1
SCHEMBL5033465 0.91 CNR1 (0.43) CNR1MEN1KMT2ANPC1RAB9A
SCHEMBL7049236 0.89 MMP1 (0.38) ROCK2MAPTHTTMMP1CYP2D6
SCHEMBL5040906 0.88 NPC1 (0.46) MAPTHTTMMP1NPC1RAB9A
SCHEMBL5036523 0.87 NPC1 (0.48) MAPTHTTMMP1NPC1RAB9A
SCHEMBL5037996 0.86 NPC1 (0.44) MAPTHTTMMP1NPC1RAB9A
SCHEMBL5036489 0.85 KDR (0.43) CYP3A4CYP2D6RAB9AKDRTEK
SCHEMBL5036005 0.85 KDR (0.46) MAPTMEN1KMT2AIDH1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432417-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2004-06-30 EP disclosed
WO-2003028721-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER AVENTIS PHARMA S.A. (FR) 2003-04-10 WO disclosed